245 related articles for article (PubMed ID: 17433228)
1. [New technologies for vaccine development].
Leclerc C
Med Sci (Paris); 2007 Apr; 23(4):386-90. PubMed ID: 17433228
[TBL] [Abstract][Full Text] [Related]
2. New approaches in vaccine development.
Leclerc C
Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620
[TBL] [Abstract][Full Text] [Related]
3. New technologies for vaccines.
Dorner F; Eibl J; Barrett PN
Wien Klin Wochenschr; 1999 Mar; 111(5):199-206. PubMed ID: 10226350
[TBL] [Abstract][Full Text] [Related]
4. [Antiviral vaccines].
Girard M
Med Trop (Mars); 1999; 59(4 Pt 2):522-6. PubMed ID: 10901858
[TBL] [Abstract][Full Text] [Related]
5. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
[TBL] [Abstract][Full Text] [Related]
6. Rational design of gene-based vaccines.
Barouch DH
J Pathol; 2006 Jan; 208(2):283-9. PubMed ID: 16362986
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous leishmaniasis: progress towards a vaccine.
Launois P; Tacchini-Cottier F; Kieny MP
Expert Rev Vaccines; 2008 Oct; 7(8):1277-87. PubMed ID: 18844599
[TBL] [Abstract][Full Text] [Related]
8. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
9. Malaria vaccine.
Khurana SK; Talib VH
Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
[TBL] [Abstract][Full Text] [Related]
10. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
11. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries.
Walker RI
Vaccine; 2005 May; 23(26):3369-85. PubMed ID: 15837361
[TBL] [Abstract][Full Text] [Related]
12. [From fundamental immunology to development of vaccinology].
Choppin J
Med Sci (Paris); 2008 Jan; 24(1):56-60. PubMed ID: 18198111
[TBL] [Abstract][Full Text] [Related]
13. Old and new vaccine approaches.
Arnon R; Ben-Yedidia T
Int Immunopharmacol; 2003 Aug; 3(8):1195-204. PubMed ID: 12860175
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. [Vaccinations and systemic diseases. Vaccinations and immunosuppression].
Bouchaud O; Mouas H
Ann Med Interne (Paris); 1998 Oct; 149(6):351-60. PubMed ID: 9853045
[TBL] [Abstract][Full Text] [Related]
16. Immunoprophylaxis of tuberculosis: an update of emerging trends.
Singhal N; Bisht D; Joshi B
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):97-106. PubMed ID: 20140756
[TBL] [Abstract][Full Text] [Related]
17. [Historical aspects of some infectious diseases: is their gradual eradication utopian?].
Werner GH
Rev Hist Pharm (Paris); 2009 Jul; 57(362):173-92. PubMed ID: 20027794
[TBL] [Abstract][Full Text] [Related]
18. Genetically engineered vaccines: an overview.
Dertzbaugh MT
Plasmid; 1998; 39(2):100-13. PubMed ID: 9514708
[TBL] [Abstract][Full Text] [Related]
19. Strategies for designing and optimizing new generation vaccines.
Berzofsky JA; Ahlers JD; Belyakov IM
Nat Rev Immunol; 2001 Dec; 1(3):209-19. PubMed ID: 11905830
[TBL] [Abstract][Full Text] [Related]
20. [New vaccination strategies].
Plotkin SA
Bull Acad Natl Med; 2008 Mar; 192(3):511-8; discussion 518-9. PubMed ID: 18819697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
